Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice

Luisa Riccardi, Emanuela Mazzon, Stefano Bruscoli, Emanuela Esposito, Concetta Crisafulli, Rosanna Di Paola, Rocco Caminiti, Carlo Riccardi, Salvatore Cuzzocrea

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Glucocorticoids (GCs) are effective anti-inflammatory agents widely used in therapeutic approach to treatment of inflammatory bowel disease (IBD). Previous results suggest that peroxisome proliferator-activated receptor α (PPAR-α), an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. With the aim to characterize the role of PPAR-α in GC-mediated anti-inflammatory activity, we tested the efficacy of dexamethasone (DEX), a synthetic GC specific for GR, in an experimental model of IBD induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-α (PPAR-αKO) with wild-type (WT) mice. Results indicate that DEX-mediated antiinflammatory activity is weakened in PPAR-αKO mice as compared with WT controls. In particular, DEX was less effective in PPAR-αKO compared with WT mice, as evaluated by inhibition of proinflammatory cytokines production, cell migration, oxidative stress, apoptosis, and colon injury. These results indicate that PPAR-α can contribute to the anti-inflammatory activity of GCs in IBD.

Original languageEnglish
Pages (from-to)308-316
Number of pages9
JournalShock
Volume31
Issue number3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Peroxisome Proliferator-Activated Receptors
Inflammatory Bowel Diseases
Glucocorticoids
Anti-Inflammatory Agents
Dexamethasone
Dinitrobenzenes
Sulfonic Acids
Cell Movement
Colon
Oxidative Stress
Transcription Factors
Theoretical Models
Fatty Acids
Apoptosis
Cytokines
Inflammation
Wounds and Injuries

Keywords

  • Bowel disease
  • Cytokines
  • Dexamethasone
  • Glucocorticoids
  • Ppar-α

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine
  • Medicine(all)

Cite this

Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. / Riccardi, Luisa; Mazzon, Emanuela; Bruscoli, Stefano; Esposito, Emanuela; Crisafulli, Concetta; Paola, Rosanna Di; Caminiti, Rocco; Riccardi, Carlo; Cuzzocrea, Salvatore.

In: Shock, Vol. 31, No. 3, 03.2009, p. 308-316.

Research output: Contribution to journalArticle

Riccardi, L, Mazzon, E, Bruscoli, S, Esposito, E, Crisafulli, C, Paola, RD, Caminiti, R, Riccardi, C & Cuzzocrea, S 2009, 'Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice', Shock, vol. 31, no. 3, pp. 308-316. https://doi.org/10.1097/SHK.0b013e31818339e7
Riccardi, Luisa ; Mazzon, Emanuela ; Bruscoli, Stefano ; Esposito, Emanuela ; Crisafulli, Concetta ; Paola, Rosanna Di ; Caminiti, Rocco ; Riccardi, Carlo ; Cuzzocrea, Salvatore. / Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice. In: Shock. 2009 ; Vol. 31, No. 3. pp. 308-316.
@article{070bd2b5056c479096d1d10989f62fc7,
title = "Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice",
abstract = "Glucocorticoids (GCs) are effective anti-inflammatory agents widely used in therapeutic approach to treatment of inflammatory bowel disease (IBD). Previous results suggest that peroxisome proliferator-activated receptor α (PPAR-α), an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. With the aim to characterize the role of PPAR-α in GC-mediated anti-inflammatory activity, we tested the efficacy of dexamethasone (DEX), a synthetic GC specific for GR, in an experimental model of IBD induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-α (PPAR-αKO) with wild-type (WT) mice. Results indicate that DEX-mediated antiinflammatory activity is weakened in PPAR-αKO mice as compared with WT controls. In particular, DEX was less effective in PPAR-αKO compared with WT mice, as evaluated by inhibition of proinflammatory cytokines production, cell migration, oxidative stress, apoptosis, and colon injury. These results indicate that PPAR-α can contribute to the anti-inflammatory activity of GCs in IBD.",
keywords = "Bowel disease, Cytokines, Dexamethasone, Glucocorticoids, Ppar-α",
author = "Luisa Riccardi and Emanuela Mazzon and Stefano Bruscoli and Emanuela Esposito and Concetta Crisafulli and Paola, {Rosanna Di} and Rocco Caminiti and Carlo Riccardi and Salvatore Cuzzocrea",
year = "2009",
month = "3",
doi = "10.1097/SHK.0b013e31818339e7",
language = "English",
volume = "31",
pages = "308--316",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Peroxisome proliferator-activated receptor-α modulates the anti-inflammatory effect of glucocorticoids in a model of inflammatory bowel disease in mice

AU - Riccardi, Luisa

AU - Mazzon, Emanuela

AU - Bruscoli, Stefano

AU - Esposito, Emanuela

AU - Crisafulli, Concetta

AU - Paola, Rosanna Di

AU - Caminiti, Rocco

AU - Riccardi, Carlo

AU - Cuzzocrea, Salvatore

PY - 2009/3

Y1 - 2009/3

N2 - Glucocorticoids (GCs) are effective anti-inflammatory agents widely used in therapeutic approach to treatment of inflammatory bowel disease (IBD). Previous results suggest that peroxisome proliferator-activated receptor α (PPAR-α), an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. With the aim to characterize the role of PPAR-α in GC-mediated anti-inflammatory activity, we tested the efficacy of dexamethasone (DEX), a synthetic GC specific for GR, in an experimental model of IBD induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-α (PPAR-αKO) with wild-type (WT) mice. Results indicate that DEX-mediated antiinflammatory activity is weakened in PPAR-αKO mice as compared with WT controls. In particular, DEX was less effective in PPAR-αKO compared with WT mice, as evaluated by inhibition of proinflammatory cytokines production, cell migration, oxidative stress, apoptosis, and colon injury. These results indicate that PPAR-α can contribute to the anti-inflammatory activity of GCs in IBD.

AB - Glucocorticoids (GCs) are effective anti-inflammatory agents widely used in therapeutic approach to treatment of inflammatory bowel disease (IBD). Previous results suggest that peroxisome proliferator-activated receptor α (PPAR-α), an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. With the aim to characterize the role of PPAR-α in GC-mediated anti-inflammatory activity, we tested the efficacy of dexamethasone (DEX), a synthetic GC specific for GR, in an experimental model of IBD induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-α (PPAR-αKO) with wild-type (WT) mice. Results indicate that DEX-mediated antiinflammatory activity is weakened in PPAR-αKO mice as compared with WT controls. In particular, DEX was less effective in PPAR-αKO compared with WT mice, as evaluated by inhibition of proinflammatory cytokines production, cell migration, oxidative stress, apoptosis, and colon injury. These results indicate that PPAR-α can contribute to the anti-inflammatory activity of GCs in IBD.

KW - Bowel disease

KW - Cytokines

KW - Dexamethasone

KW - Glucocorticoids

KW - Ppar-α

UR - http://www.scopus.com/inward/record.url?scp=62449207118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62449207118&partnerID=8YFLogxK

U2 - 10.1097/SHK.0b013e31818339e7

DO - 10.1097/SHK.0b013e31818339e7

M3 - Article

C2 - 18665053

AN - SCOPUS:62449207118

VL - 31

SP - 308

EP - 316

JO - Shock

JF - Shock

SN - 1073-2322

IS - 3

ER -